264 related articles for article (PubMed ID: 29580282)
1. Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
Wang J; Lv H; Luo Z; Mou S; Liu J; Liu C; Deng S; Jiang Y; Lin J; Wu C; Liu X; He J; Jiang D
Respir Res; 2018 Mar; 19(1):47. PubMed ID: 29580282
[TBL] [Abstract][Full Text] [Related]
2. Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap.
Shirai T; Hirai K; Gon Y; Maruoka S; Mizumura K; Hikichi M; Holweg C; Itoh K; Inoue H; Hashimoto S
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):134-145.e1. PubMed ID: 29981861
[TBL] [Abstract][Full Text] [Related]
3. Sputum Neutrophil Gelatinase-Associated Lipocalin as a Biomarker in Asthma-COPD Overlap.
Babu A; Narayanswamy H; Baburao A
J Assoc Physicians India; 2023 Sep; 71(9):34-38. PubMed ID: 38700299
[TBL] [Abstract][Full Text] [Related]
4. Characterization of sputum biomarkers for asthma-COPD overlap syndrome.
Gao J; Iwamoto H; Koskela J; Alenius H; Hattori N; Kohno N; Laitinen T; Mazur W; Pulkkinen V
Int J Chron Obstruct Pulmon Dis; 2016; 11():2457-2465. PubMed ID: 27757028
[TBL] [Abstract][Full Text] [Related]
5. Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease.
Han SS; Lee WH; Hong Y; Kim WJ; Yang J; Lim MN; Lee SJ; Kwon JW
J Asthma; 2016 Aug; 53(6):583-8. PubMed ID: 27104648
[TBL] [Abstract][Full Text] [Related]
6. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
7. Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort.
Park HY; Lee SY; Kang D; Cho J; Lee H; Lim SY; Yoon HI; Ra SW; Kim KU; Oh YM; Sin DD; Lee SD; Park YB
Respir Res; 2018 Mar; 19(1):36. PubMed ID: 29499758
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil gelatinase-associated lipocalin as a complementary biomarker for the asthma-chronic obstructive pulmonary disease overlap.
Jo YS; Kwon SO; Kim J; Kim WJ
J Thorac Dis; 2018 Aug; 10(8):5047-5056. PubMed ID: 30233879
[TBL] [Abstract][Full Text] [Related]
9. Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma-COPD overlap.
Gao J; Zhou W; Chen B; Lin W; Wu S; Wu F
Int J Chron Obstruct Pulmon Dis; 2017; 12():2703-2710. PubMed ID: 28979112
[TBL] [Abstract][Full Text] [Related]
10. Asthma-COPD overlap is not a homogeneous disorder: further supporting data.
Pérez-de-Llano L; Cosio BG;
Respir Res; 2017 Nov; 18(1):183. PubMed ID: 29096609
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO).
Ghosh N; Choudhury P; Kaushik SR; Arya R; Nanda R; Bhattacharyya P; Roychowdhury S; Banerjee R; Chaudhury K
Respir Res; 2020 May; 21(1):126. PubMed ID: 32448302
[TBL] [Abstract][Full Text] [Related]
12. Decreased serum club cell secretory protein in asthma and chronic obstructive pulmonary disease overlap: a pilot study.
Oh JY; Lee YS; Min KH; Hur GY; Lee SY; Kang KH; Rhee CK; Park SJ; Shim JJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():3411-3417. PubMed ID: 30425470
[TBL] [Abstract][Full Text] [Related]
13. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
Iwamoto H; Gao J; Koskela J; Kinnula V; Kobayashi H; Laitinen T; Mazur W
Eur Respir J; 2014 Feb; 43(2):421-9. PubMed ID: 23794464
[TBL] [Abstract][Full Text] [Related]
14. Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.
James AJ; Reinius LE; Verhoek M; Gomes A; Kupczyk M; Hammar U; Ono J; Ohta S; Izuhara K; Bel E; Kere J; Söderhäll C; Dahlén B; Boot RG; Dahlén SE;
Am J Respir Crit Care Med; 2016 Jan; 193(2):131-42. PubMed ID: 26372680
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics Of Patients With Asthma COPD Overlap (ACO) In Australian Primary Care.
Izbicki G; Teo V; Liang J; Russell GM; Holland AE; Zwar NA; Bonevski B; Mahal A; Eustace P; Paul E; Phillips K; Wilson S; George J; Abramson MJ
Int J Chron Obstruct Pulmon Dis; 2019; 14():2745-2752. PubMed ID: 31819406
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease.
Pérez de Llano L; Cosío BG; Miravitlles M; Plaza V;
Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):198-204. PubMed ID: 29229474
[TBL] [Abstract][Full Text] [Related]
17. Clinical Indicators for Asthma-COPD Overlap: A Systematic Review and Meta-Analysis.
Peng J; Wang M; Wu Y; Shen Y; Chen L
Int J Chron Obstruct Pulmon Dis; 2022; 17():2567-2575. PubMed ID: 36259043
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA-15b-5p as a biomarker for asthma-COPD overlap.
Hirai K; Shirai T; Shimoshikiryo T; Ueda M; Gon Y; Maruoka S; Itoh K
Allergy; 2021 Mar; 76(3):766-774. PubMed ID: 32713026
[TBL] [Abstract][Full Text] [Related]
19. Utility of serum YKL-40 levels for identification of patients with asthma and COPD.
Gon Y; Maruoka S; Ito R; Mizumura K; Kozu Y; Hiranuma H; Hattori T; Takahashi M; Hikichi M; Hashimoto S
Allergol Int; 2017 Oct; 66(4):624-626. PubMed ID: 28285848
[No Abstract] [Full Text] [Related]
20. Smoking history and emphysema in asthma-COPD overlap.
Kurashima K; Takaku Y; Ohta C; Takayanagi N; Yanagisawa T; Kanauchi T; Takahashi O
Int J Chron Obstruct Pulmon Dis; 2017; 12():3523-3532. PubMed ID: 29263658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
